Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dentsply SironaXRAY -2.05%55 10-Year Share Buyback Ratio is -0.80 as of Jun. 2026. GuruFocus rates XRAY with a GF Score™ of 55/100 and a GF Value™ of $17.31 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 452 Medical Devices & Instruments companies, Dentsply Sirona ranks better than 74.34% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Dentsply Sirona's current 10-Year Share Buyback Ratio was -0.80%.
XRAY's 10-Year Share Buyback Ratio is ranked better than 74.34% of 452
companies
in the Medical Devices & Instruments industry
Industry Median: -3.35
vs XRAY: -0.80
Dentsply Sirona (NAS:XRAY) 10-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Dentsply Sirona 10-Year Share Buyback Ratio Related Terms
XRAY vs ATRC, LMAT, BLFS: 10-Year Share Buyback Ratio Comparison
For the Medical Instruments & Supplies subindustry, Dentsply Sirona's 10-Year Share Buyback Ratio, along with its competitors' market caps and 10-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dentsply Sirona 10-Year Share Buyback Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Dentsply Sirona's 10-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Dentsply Sirona's 10-Year Share Buyback Ratio falls into.
Dentsply Sirona 10-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from ten years ago to the current year. The annualized percentage change is calculated with least-square regression based on the eleven years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 10-Year Share Buyback Ratio of -0.80 mean?
Dentsply Sirona (XRAY) has a 10-Year Share Buyback Ratio of -0.80 as of Jun. 2026. The 10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. View historical data for Dentsply Sirona and its competitors. According to the industry distribution chart, Dentsply Sirona ranks #116 out of 452 companies in the Medical Devices & Instruments industry, placing it in the top 25.7%.
Is Dentsply Sirona's 10-Year Share Buyback Ratio too high?
Dentsply Sirona's current 10-Year Share Buyback Ratio is -0.80. Based on the distribution chart, Dentsply Sirona ranks #116 out of 452 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Dentsply Sirona has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dentsply Sirona's 10-Year Share Buyback Ratio compare to ATRC and LMAT?
According to the Medical Devices & Instruments industry distribution chart, Dentsply Sirona ranks #116 out of 452 companies for 10-Year Share Buyback Ratio. This puts Dentsply Sirona in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year Share Buyback Ratio for a Medical Devices & Instruments company?
A good 10-Year Share Buyback Ratio depends on the Medical Devices & Instruments industry context. However, 10-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year Share Buyback Ratio mean?
A high 10-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. View historical data for Dentsply Sirona and its competitors. Dentsply Sirona's current 10-Year Share Buyback Ratio is -0.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dentsply Sirona stock overvalued right now?
Based on GuruFocus' analysis, Dentsply Sirona (XRAY) is currently considered Possible Value Trap. The stock's GF Value™ is $17.31, compared to a current price of $10.51 — trading 39.3% below its estimated fair value. The current 10-Year Share Buyback Ratio is -0.80. Dentsply Sirona's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year Share Buyback Ratio calculated?
10-Year Share Buyback Ratio is calculated from a company's financial statements. For Dentsply Sirona (XRAY), the current 10-Year Share Buyback Ratio is -0.80 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dentsply Sirona (XRAY) Overvalued in 2026?
Based on GuruFocus' analysis, Dentsply Sirona stock appears to be undervalued.
The current stock price of $10.51 is trading 39.3% below its estimated GF Value™ of $17.31.
GuruFocus considers Dentsply Sirona to be Possible Value Trap.
Key valuation signals for XRAY:
10-Year Share Buyback Ratio: -0.80
GF Value™: $17.31 vs. price of $10.51 (39.3% below fair value)
No single metric tells the full story. See the XRAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
55GF Score
Get the complete analysis for XRAY
10-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XRAY has been successfully added to your 
